Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (27,941,000)	$ (14,894,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	660,000	876,000
Stock based compensation expense	1,280,000	551,000
(Recovery of) reserve for excess and slow-moving inventories	(37,000)	451,000
Amortization of debt discount	9,851,000	5,189,000
Amortization of debt issue costs	160,000	785,000
Change in fair value of derivative	104,000	(3,152,000)
Non-cash accrued interest	10,373,000
Loss on disposal of equipment	70,000
Loss on cashless exercise of warrants		1,039,000
Loss on extinguishment of debt		795,000
Loss on modification of Series A warrants		149,000
Net change in operating assets and liabilities:
Accounts receivable	224,000	1,040,000
Inventories	599,000	568,000
Prepaid expenses and other current assets	(86,000)	(301,000)
Other assets	16,000
Accounts payable	(738,000)	(1,733,000)
Related party payable	606,000
Accrued payroll and related expenses	(142,000)	(384,000)
Deferred revenue	(96,000)	(87,000)
Other current liabilities	(100,000)	368,000
Other noncurrent liabilities	84,000	391,000
Net cash used in operating activities	(5,113,000)	(8,349,000)
Net cash used in investing activities:
Capital expenditures	(310,000)	(602,000)
Cash flows from financing activities:
Gross proceeds from convertible debentures		18,000,000
Proceeds from long term debt – related party	1,500,000
Payment of financing cost	(13,000)	(961,000)
Repayment of convertible debentures		(6,444,000)
Payment to extinguish derivative obligations		(159,000)
Payments on capital lease obligations	(68,000)	(46,000)
Proceeds from issuance of common stock, net	2,091,000	2,463,000
Repurchase of common stock	(134,000)	(5,000)
Net cash provided by financing activities	3,376,000	12,848,000
Effects of foreign currency rate changes on cash and cash equivalents	3,000	(7,000)
Net increase (decrease) in cash and cash equivalents	(2,044,000)	3,890,000
Cash and cash equivalents at beginning of period	5,835,000	3,357,000
Cash and cash equivalents at end of period	3,791,000	7,247,000
Supplemental non-cash financing and investing information:
Common stock issued for payment of convertible debenture and interest	23,905,000
Derivative obligation related to issuance of warrants		4,282,000
Transfer of equipment to inventories	$ 625,000